Genetic predisposition, nongenetic risk factors, and coronary infarct

Archives of Internal Medicine

Volumn 168, Issue 8, 2008, Pages 891-896

  Trichopoulou, Antonia ^a   Yiannakouris, Nikos ^b   Bamia, Christina ^a   Benetou, Vassiliki ^a   Trichopoulos, Dimitrios ^c,d   Ordovas, Jose M ^e  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c HELLENIC HEALTH FOUNDATION   (Greece)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1BETA; LIPOPROTEIN LIPASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GREECE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; NUCLEOTIDE SEQUENCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

CASE-CONTROL STUDIES; DIET, MEDITERRANEAN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TREATMENT REFUSAL;

EID: 42949160705     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.8.891     Document Type: Article

References (29)

1. Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98(23):1694-1706.
2. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-678.
3. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881-885.
4. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA. 2007;297(14):1551-1561.
5. Ioannidis JP. Non-replication and inconsistency in the genome-wide association setting. Hum Hered. 2007;64(4):203-213.
6. Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet. 2001;358(9276):115-119.
7. Ordovas JM, Corella D, Demissie S, et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation. 2002;106(18):2315-2321.
8. Trichopoulos D, Lagiou P. Dietary patterns and mortality. Br J Nutr. 2001;85(2):133-134.
9. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348(26):2599-2608.
10. Gosling P, Brudney S, McGrath L, Riseboro S, Manji M. Mortality at admission to intensive care: a comparison of microalbuminuria with acute physiology scores after 24 hours. Crit Care Med. 2003;31(1):98-103.
11. Yiannakouris N, Trichopoulou A, Benetou V, Psaltopoulou T, Ordovas JM, Trichopoulos D. A direct assessment of genetic contribution to the incidence of coronary infarct in the general population Greek EPIC cohort. Eur J Epidemiol. 2006;21(12):859-867.
12. Danesh J, Saracci R, Berglund G, et al. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol. 2007;22(2):129-141.
13. Bamia C, Trichopoulou A, Lenas D, Trichopoulos D. Tobacco smoking in relation to body fat mass and distribution in a general population simple. Int J Obes Relat Metab Disord. 2004;28(8):1091-1096.
14. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol. 2004;33(6):1345-1352.
15. Benetou V, Bamia C, Trichopoulos D, Trichopoulou A. Associations of anthropometric characteristics with blood cholesterol fractions among adults: the Greek EPIC Study. Eur J Clin Nutr. 2006;60(8):942-948.
16. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976;103(5):506-511.
17. Ahlbom A, Alfredsson L. Interaction: a word with two meanings creates confusion. Eur J Epidemiol. 2005;20(7):563-564.
18. Wood D; Joint European Societies Task Force. Established and emerging cardiovascular risk factors. Am Heart J. 2001;141(2)(suppl):S49-S57.
19. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141(2):137-147.
20. Lai CQ, Parnell LD, Ordovas JM. The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol. 2005;16(2):153-166.
21. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease: a meta-analysis. Circulation. 1999;99(22):2901-2907.
22. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002;288(16):2023-2031.
23. Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109(11):1359-1365.
24. Iacoviello L, Di Castelnuovo A, Gattone M, et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol. 2005;25(1):222-227.
25. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6-174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J. 2001;22(24):2243-2252.
26. Sookoian SC, González C, Pirola CJ. Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res. 2005;13(12):2122-2131.
27. Samani NJ, Erdmann J, Hall AS, et al; WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357(5):443-453.
28. Bertuzzi M, Negri E, Tavani A, La Vecchia C. Family history of ischemic heart disease and risk of acute myocardial infarction. Prev Med. 2003;37(3):183-187.
29. Jacques PF, Tucker KL. Are dietary patterns useful for understanding the role of diet in chronic disease? Am J Clin Nutr. 2001;73(1):1-2.